Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Open Label, Parallel Group, Multi-center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf or Prograf Based Immunosuppressive Regimen, Including a Long-term Follow-up

Next Previous
X
Search
Trial Profile

A Phase II, Open Label, Parallel Group, Multi-center Study to Compare the Pharmacokinetics of Tacrolimus in Adult Subjects Undergoing Primary Allograft Transplantation Receiving an Advagraf or Prograf Based Immunosuppressive Regimen, Including a Long-term Follow-up

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Heart transplant rejection; Kidney-pancreas transplant rejection; Lung transplant rejection; Pancreas transplant rejection
  • Focus Pharmacokinetics
  • Sponsors Astellas Pharma; Astellas Pharma Europe Ltd

    • Most Recent Events

    • 18 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database
    • 22 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov. record.
    • 10 Jun 2013 Planned end date changed from 1 Jul 2016 to 1 Jul 2014 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top